You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 37 No. 2, February 1980 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Restabilization With Methadone After Methadyl Acetate Maintenance

Walter Ling, MD; Mara Blakis, MD; Elaine D. Holmes, PhD; C. James Klett, PhD; William E. Carter, PA

Arch Gen Psychiatry. 1980;37(2):194-196.


Abstract

• Sixty-eight heroin addicts maintained for 40 weeks on a regimen of methadyl acetate or methadone hydrochloride in a double-blind study were transferred to a uniform dose of 60 mg of methadone daily at the end of their tenure in the study. They were observed for the ensuing six weeks, during which their daily methadone doses were adjusted according to their clinical needs. Patients were observed for symptoms and signs of discomfort and for the amount of illicit drug use during this period of transition. The results indicate that patients maintained on a regimen of methadyl acetate can be readily restabilized with methadone and that sudden decrease of the methadone dose tends to result in the patient's supplementing with illicit heroin. Conversely, increasing methadone doses resulted in a corresponding reduction in illicit drug use. It is suggested that a chronic covert abstinence syndrome may exist in some patients receiving long-term methadone maintenance therapy, and that while it may contribute to their continued illicit drug use, it may have a different pathophysiologic basis and require different therapeutic considerations.



Author Affiliations

From the Veterans Administration Hospital, Sepulveda, Calif (Drs Ling, Blakis, and Holmes, and Mr Carter), and the Veterans Administration Hospital, Perry Point, Md (Dr Klett).


Footnotes

Accepted for publication Dec 26, 1978.

Reprint requests to Veterans Administration Medical Center, 16111 Plummer St, Sepulveda, CA 91343 (Dr Ling).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Methadone Treatment and Acquired Immunodeficiency Syndrome
Cooper
JAMA 1989;262:1664-1668.
ABSTRACT  

Methadyl Acetate (LAAM) in the Treatment of Heroin Addicts: II. Double-blind Comparison of Gradual and Abrupt Detoxification
Judson et al.
Arch Gen Psychiatry 1983;40:834-840.
ABSTRACT  

Long-term Follow-up of Clients of High- and Low-Dose Methadone Programs: Dr McGlothlin died shortly after this article was accepted. For the field and for many colleagues it is a loss that is keenly felt.--ED.
McGlothlin and Anglin
Arch Gen Psychiatry 1981;38:1055-1063.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.